Abstract
The Foreign Commonwealth and Development Office (FCDO)’s East Africa Research Hub and the Bill and Melinda Gates Foundation are funding a series of linked seroepidemiological studies to monitor, understand, and inform the COVID-19 response in Kenya. This study, currently underway, is led by investigators from the KEMRI-Wellcome Trust Research Programme.
Serosurveillance of convenient samples of the population can allow interpretations to be made about the collective occurrence of infection to date. A first in the region, this ambitious study plans to measure SARS-CoV-2 antibody prevalence among blood donors; in attendees at ante-natal care clinics; among healthcare workers; among frontline staff in key non-healthcare service areas; among populations in Demographic Surveillance Systems; in PCR-confirmed asymptomatic cases; and, in PCR-confirmed non-severe and severe symptomatic cases.